Narrative review of laparoscopic management of hepatic cysts

 



Executive Summary

Hepatic cysts represent a diverse spectrum of liver lesions, the majority of which are benign, asymptomatic, and discovered incidentally. While simple cysts under 5 cm typically require no intervention, larger or symptomatic lesions often necessitate surgical management.

Minimally invasive surgery (MIS), encompassing both laparoscopic and robotic approaches, has emerged as the standard of care for symptomatic hepatic cysts. Key findings from clinical literature indicate:

  • High Efficacy: Symptomatic relief is achieved in approximately 90.2% of cases following laparoscopic intervention.

  • Safety Profile: Mortality rates are remarkably low (below 1%), with major complications (Clavien-Dindo 3–4) occurring in only 3.3% of patients.

  • Recurrence Variability: While simple cysts have a recurrence rate below 10%, Polycystic Liver Disease (PLD) presents a significantly higher challenge, with recurrence rates near 33.7%.

  • Technical Precision: Success in marsupialization (unroofing) depends on the resection of a large section of the cyst wall (typically with a 1 cm margin) and the use of advanced imaging, such as Indocyanine Green (ICG), to prevent bile leaks.

Classification and Etiology of Hepatic Cysts

Hepatic cysts are primarily categorized into congenital and acquired lesions. Precise classification is vital as it dictates the surgical algorithm and risk profile.

General Classification

  • Congenital: Includes simple cysts and Polycystic Liver Disease (PLD). These arise from malformations of the ductal plate and are lined with biliary epithelium.

  • Acquired:

    • Infectious: Pyogenic (bacterial) or parasitic (Hydatid/Amebic).

    • Neoplastic: Biliary cystadenoma or cystadenocarcinoma.

Polycystic Liver Disease (Gigot Classification)

The Gigot classification system is employed to guide treatment for PLD, which is often associated with autosomal dominant polycystic kidney disease (AD-PKD).

Type

Description

Type I

Less than 10 large hepatic cysts (diameter >10 cm).

Type II

Diffuse involvement by multiple cysts with large remaining areas of normal parenchyma.

Type III

Diffuse involvement by small/medium cysts with very few areas of normal parenchyma.

Hydatid Cysts (Gharbi Classification)

Caused by Echinococcus granulosum, these parasitic cysts require specific handling to avoid anaphylaxis.

Type

Description

Type I

Pure fluid collection (can mimic congenital cysts).

Type II

Fluid collection with a detached membrane.

Type III

Fluid collection with multiple septae and/or daughter cysts.

Type IV

Hyperechoic with internal echoes.

Type V

Cyst with a reflecting, calcified, thick wall.

Clinical Presentation and Diagnostic Indications

Symptoms

While small cysts (<5 cm) are generally asymptomatic, larger cysts can cause significant morbidity due to the compression of adjacent organs:

  • Gastrointestinal: Satiety, nausea, anorexia, and gastroesophageal reflux disease (GERD) resulting from gastric compression.

  • Respiratory: Dyspnea due to diaphragmatic displacement.

  • General: Abdominal pain, weight loss, and palpable masses.

  • Complications: Rarely, cysts may lead to bleeding, secondary infection, or biliary obstruction.

Imaging Modalities

  • Ultrasound: The primary mode for initial detection and monitoring of small cysts.

  • CT and MRI: Critical for preoperative planning. These modalities help distinguish between simple cysts, PLD, and hydatid disease; they also identify the relationship of the cyst to portal or hepatic branches and evidence of intracavitary bleeding.

Surgical Techniques and Technical Considerations

Laparoscopic Marsupialization (Unroofing)

This is the preferred technique for simple cysts and involves the wide excision of the cyst wall to allow the fluid to drain into the peritoneum, where it is reabsorbed.

  • Access: Usually performed in the supine position (anterior cysts) or lateral decubitus (posterior cysts).

  • Wall Resection: A large section of the outer wall must be resected without crossing into normal liver parenchyma. A 1 cm margin to the edge of the cyst is recommended.

  • Hemostasis: Advanced energy devices, such as ultrasonic shears or bipolar vessel sealers, are preferred over standard monopolar cautery to ensure hemostasis.

Adjunctive Procedures

  • Fulguration/Ablation: Using argon beam coagulation to treat the cyst lining may reduce secretory capacity and lower recurrence risks.

  • Omentopexy: Placing omentum into the cyst cavity is sometimes used for superiorly located cysts where the diaphragm might otherwise "re-roof" the lesion.

  • Indocyanine Green (ICG): Near-infrared imaging with ICG facilitates the detection of exposed biliary radicals, helping to prevent postoperative bile leaks.

Management of Complex Cystic Lesions

Hydatid (Parasitic) Cysts

Management is focused on preventing the spillage of cyst contents to avoid anaphylaxis.

  • Medical: Pre-operative treatment with albendazole for at least 7 days.

  • Surgical: Controlled aspiration and inactivation of contents using 20% hypertonic saline.

  • Approach: While once reserved for simpler types, MIS is now considered safe even for Type III hydatid lesions. Complete cystectomy is generally avoided due to higher rates of bile leak and bleeding.

Hepatic Abscesses and Neoplastic Cysts

  • Abscesses: Primarily managed with intravenous antibiotics and percutaneous drainage. Surgical intervention is a rare last resort.

  • Neoplastic Cysts (Cystadenoma): Because these are true neoplasms that can progress to carcinoma, they require formal hepatic resection (segmental or non-anatomical) rather than simple unroofing.

Clinical Outcomes and Performance Data

Long-term follow-up and meta-analyses confirm that MIS is highly effective for hepatic cystic disease. However, outcomes vary significantly between simple cysts and PLD.

Comparative Outcomes (Laparoscopic Fenestration)

Metric

Overall (%)

PLD Specific (%)

Symptomatic Recurrence

9.6

33.7

Re-intervention Rate

7.1

26.4

Total Complications

10.8

29.3

Major Complications

3.3

7.2

Mortality

1.0

2.3

Conclusions on Efficacy

  • Simple Cysts: MIS offers excellent long-term results with low recurrence (<10%).

  • PLD: Patients with Type I and II disease benefit from fenestration, but Type III patients often require more aggressive intervention, such as formal liver resection or transplant, due to the high failure rate of simple decompression.

  • Recovery: MIS approaches provide outcomes comparable or superior to traditional laparotomy in terms of morbidity and peri-operative recovery.